Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
Leukemia|June 21, 2020
The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemiaMansour Alfayez, Ghayas C Issa, Keyur P Patel, et al.
Human Pathology|August 8, 2018
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruptionSofia Garces, Joseph D Khoury, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 10, 2015
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
American Journal of Hematology|May 15, 2023
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumorsRashmi S Goswami, Keyur P Patel, Rajesh R Singh, et al.
Bone Marrow Transplantation|January 7, 2022
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplantSiba El Hussein, Courtney D DiNardo, Koichi Takahashi, et al.
Oncotarget|February 18, 2016
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRASRashmi Kanagal-Shamanna, Rajyalakshmi Luthra, Cameron C Yin, et al.
Leukemia Research|April 17, 2022
Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemiaFatima Zahra Jelloul, Richard Yang, Sofia Garces, et al.
Blood Advances|November 19, 2020
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemiaNicholas J Short, Guillermo Montalban-Bravo, Hyunsoo Hwang, et al.
American Journal of Hematology|January 23, 2023
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitorsElias J Jabbour, Koji Sasaki, Fadi G Haddad, et al.
Pageof 23